Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.

Manabu FutamuraYasuko NagaoKazuhiro IshiharaMakoto TakeuchiTakumi NakadaYoshihiro KawaguchiMasayoshi AsanoIwao KumazawaTakashi ShirokoKasumi MorimitsuRyutaro MoriMasahito NawaToshio ShimokawaKazuhiro Yoshida

Published in: Breast cancer (Tokyo, Japan) (2017)

Preoperative NAC with nab-PTX followed by EC is effective and safe for operable breast cancer.

Keyphrases

neoadjuvant chemotherapy
locally advanced
patients undergoing
lymph node
sentinel lymph node
transcription factor
low dose
high dose
open label
clinical trial
radiation therapy